Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.
From the official U.S. FDA label for 10% DEXTROSE INFUSION $, the active ingredient registered with NAFDAC.
1. INDICATIONS AND USAGE 10% Dextrose Injection is indicated as source of water and calories.
The most common adverse reactions are, hyperglycemia, hypersensitivity reactions, hyponatremia, infection both systemic and at the injection site, vein thrombosis or phlebitis, and electrolyte imbalance. (6) To report SUSPECTED ADVERSE REACTIONS, contact Fresenius Kabi USA, LLC at 1-800-551- 7176 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Clinically significant hyperglycemia. (4) Known hypersensitivity to dextrose. (4)
Hyperglycemia or Hyperosmolar Hyperglycemic State: Monitor blood glucose and administer insulin as needed. (5.1) Hypersensitivity Reactions: Monitor for signs and symptoms and discontinue infusion if reactions occur. (5.2) Vein Damage and Thrombosis: Consider central vein when administering more than 5% dextrose or with an osmolarity of at least 900 mOsm/L or when there is peripheral vein irritation, phlebitis, and/or associated pain. (2.2, 5.3) Hyponatremia: Avoid in patients with or at risk for hyponatremia. If use cannot be avoided, monitor serum sodium concentrations. (5.4) Electrolyte Imbalance and Fluid Overload: Avoid in patients with or at risk for fluid and/or solute overloading. …
8.1 Pregnancy Risk Summary Appropriate administration of 10% Dextrose Injection during pregnancy is not expected to cause adverse developmental outcomes, including congenital malformations. Animal reproduction studies have not been conducted with injectable dextrose solutions. The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. …
Add the expiry date on your pack for a full Trust Score.
10% DEXTROSE INFUSION $ contains Dextrose Anhydrous (10%), as solution for infusion, according to its NAFDAC registration record.
Yes. 10% DEXTROSE INFUSION $ is listed on the NAFDAC register under registration number A11-0237, and its registration is active as of 27 October 2026.
No WHO falsified or substandard medical product alert currently matches 10% DEXTROSE INFUSION $ in our automatically synced alert list.
Run a free authenticity scan with the NAFDAC number A11-0237, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.
1. INDICATIONS AND USAGE 10% Dextrose Injection is indicated as source of water and calories. (Summarised from the official U.S. FDA label for 10% DEXTROSE INFUSION $. Always follow your doctor or pharmacist.)
Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.